Related Articles
VEGF‑C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin
Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin
Silencing of the transcriptional factor ZEB1 alters the steroidogenic pathway, and increases the concentration of testosterone and DHT in DU145 cells
Silencing of ECHDC1 inhibits growth of gemcitabine‑resistant bladder cancer cells
Blocking integrin β1 decreases adhesion in chemoresistant urothelial cancer cell lines